Table 3 Montreal Cognitive Assessment of patients with COVID-19
From: Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients
Patient # (age) | Executive (max. 5) | Naming (max. 3) | Attention (max. 6) | Language (max. 3) | Abstraction (max. 2) | Delayed Recall (max. 5) | Orientation (max. 6) | Total Points (max. 30) |
|---|---|---|---|---|---|---|---|---|
1 (51) | 5 | 3 | 6 | 2 | 2 | 5 | 6 | 29 |
3 (32) | 3 | 3 | 6 | 3 | 2 | 5 | 6 | 28 |
4 (49) | 5 | 3 | 6 | 3 | 2 | 1 | 4 | 24 |
6 (77)a | 0 | 3 | 1 | 1 | 0 | 0 | 6 | 11 |
7 (80) | 4 | 3 | 4 | 0 | 1 | 2 | 6 | 20 |
11 (70) | 3 | 3 | 6 | 2 | 2 | 2 | 6 | 24 |
12 (66) | 4 | 3 | 6 | 3 | 2 | 2 | 6 | 26 |
14 (54) | 5 | 3 | 6 | 3 | 2 | 2 | 6 | 27 |
15 (61) | 5 | 3 | 4 | 2 | 2 | 4 | 6 | 26 |
18 (60)b | 2 | 3 | 3 | 2 | 2 | 1 | 3 | 16 |
19 (59) | 3 | 3 | 4 | 2 | 2 | 4 | 6 | 22 |
20 (53) | 5 | 3 | 5 | 1 | 2 | 0 | 6 | 22 |
21 (75) | 3 | 3 | 5 | 0 | 2 | 5 | 6 | 24 |
Mean (SD) | 3.62 (1.50) | 3 (0) | 4.77 (1.54) | 1.85 (1.07) | 1.77 (0.60) | 2.54 (1.85) | 5.62 (0.96) | 23 (5.02) |